Health
Inhibition of Meprin Β enzyme can trigger the development of Alzheimer’s disease, cancer – News-Medical.Net
Researchers at Johannes Gutenberg University Mainz (JGU) in Germany and the Institute of Molecular Biology of Barcelona in Spain have discovered how the blood plasma…
Researchers at Johannes Gutenberg University Mainz (JGU) in Germany and the Institute of Molecular Biology of Barcelona in Spain have discovered how the blood plasma protein fetuin-B binds to the enzyme meprin β and used a computer model to visualize their findings.
These results could lead to the development of new drugs to treat serious diseases such as Alzheimer’s and cancer. Meprin β releases proteins from cell membranes, thus controlling important physiological functions in the human body.
…
-
Noosa News21 hours agoEnsure voices are heard – Proctor
-
Business19 hours agoUp 34% this year, can Challenger shares keep rising according to Macquarie?
-
Noosa News23 hours agoCity of Moreton Bay claims homeless people consented to having camps thrown away
-
General22 hours agoReserve Bank board still looking for yesterday’s news